<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Nutr Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Nutr Sci</journal-id><journal-id journal-id-type="publisher-id">JNS</journal-id><journal-title-group><journal-title>Journal of Nutritional Science</journal-title></journal-title-group><issn pub-type="epub">2048-6790</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25191556</article-id><article-id pub-id-type="pmc">4153032</article-id><article-id pub-id-type="doi">10.1017/jns.2012.10</article-id><article-id pub-id-type="pii">S2048679012000109</article-id><article-id pub-id-type="publisher-id">00010</article-id><article-categories><subj-group subj-group-type="heading"><subject>Human and Clinical Nutrition</subject></subj-group></article-categories><title-group><article-title>Intake of polyphenol-rich pomegranate pure juice influences urinary
glucocorticoids, blood pressure and homeostasis model assessment of insulin resistance in
human volunteers</article-title><alt-title alt-title-type="left-running">C. Tsang <italic>et al.</italic></alt-title><alt-title alt-title-type="right-running">Pomegranate juice and markers of CVD</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tsang</surname><given-names>Catherine</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Smail</surname><given-names>Nacer F.</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Almoosawi</surname><given-names>S.</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Davidson</surname><given-names>I.</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Al-Dujaili</surname><given-names>Emad A. S.</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff1">Department of Dietetics, Nutrition and Biological Sciences, Queen Margaret
University, Queen Margaret University Drive, Musselburgh, East Lothian EH21 6UU, UK</aff><author-notes><corresp id="cor1"><label>*</label><bold>Corresponding author:</bold> Dr E. A. S.
Al-Dujaili, fax +44 131 474 0001, email <email xlink:href="ealdujaili@qmu.ac.uk">ealdujaili@qmu.ac.uk</email></corresp></author-notes><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>31</day><month>8</month><year>2012</year></pub-date><volume>1</volume><elocation-id>e9</elocation-id><history><date date-type="received"><day>16</day><month>1</month><year>2012</year></date><date date-type="rev-recd"><day>14</day><month>6</month><year>2012</year></date><date date-type="accepted"><day>04</day><month>7</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9; The Author(s) 2012</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/2.5/"><license-p><!--CREATIVE COMMONS-->The online version of this article is published within an Open Access environment
subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike
licence &#x0003c;<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/2.5/">http://creativecommons.org/licenses/by-nc-sa/2.5/</ext-link>&#x0003e;. The written
permission of Cambridge University Press must be obtained for commercial re-use.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="S2048679012000109a.pdf"/><abstract><p>Pomegranate juice (PJ; also known as pomegreat pure juice) provides a rich and varied
source of polyphenolic compounds that may offer cardioprotective, anti-atherogenic and
antihypertensive effects. The aim of this study was to investigate the effect of PJ
consumption on glucocorticoids levels, blood pressure (BP) and insulin resistance in
volunteers at high CVD risk. Subjects (twelve males and sixteen females) participated in a
randomised, placebo-controlled cross-over study (BMI: 26&#x000b7;77&#x000a0;(<sc>sd</sc>
3&#x000b7;36)&#x000a0;kg/m<sup>2</sup>; mean age: 50&#x000b7;4&#x000a0;(<sc>sd</sc> 6&#x000b7;1) years). Volunteers were assessed
at baseline, and at weeks 2 and 4 for anthropometry, BP and pulse wave velocity. Cortisol
and cortisone levels in urine and saliva were determined by specific ELISA methods, and
the cortisol/cortisone ratio was calculated. Fasting blood samples were obtained to assess
plasma lipids, glucose, insulin and insulin resistance (homeostasis model assessment of
insulin resistance). Volunteers consumed 500&#x000a0;ml of PJ or 500&#x000a0;ml of a placebo drink
containing a similar amount of energy. Cortisol urinary output was reduced but not
significant. However, cortisol/cortisone ratios in urine (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;009) and
saliva (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;024) were significantly decreased. Systolic BP decreased
from 136&#x000b7;4&#x000a0;(<sc>sd</sc>&#x000a0;6&#x000b7;3) to 128&#x000b7;9&#x000a0;(<sc>sd</sc>&#x000a0;5&#x000b7;1)&#x000a0;mmHg (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;034),
and diastolic BP from 80&#x000b7;3&#x000a0;(<sc>sd</sc>&#x000a0;4&#x000b7;29) to 75&#x000b7;5&#x000a0;(<sc>sd</sc>&#x000a0;5&#x000b7;17)&#x000a0;mmHg
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;031) after 4 weeks of fruit juice consumption. Pulse wave velocity
decreased from 7&#x000b7;5&#x000a0;(<sc>sd</sc>&#x000a0;0&#x000b7;86) to 7&#x000b7;44&#x000a0;(<sc>sd</sc>&#x000a0;0&#x000b7;94)&#x000a0;m/s
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;035). There was also a significant reduction in fasting plasma
insulin from 9&#x000b7;36&#x000a0;(<sc>sd</sc>&#x000a0;5&#x000b7;8) to 7&#x000b7;53&#x000a0;(<sc>sd</sc>&#x000a0;4&#x000b7;12)&#x000a0;mIU/l
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;025) and of homeostasis model assessment of insulin resistance
(from 2&#x000b7;216&#x000a0;(<sc>sd</sc>&#x000a0;1&#x000b7;43) to 1&#x000b7;82&#x000a0;(<sc>sd</sc>&#x000a0;1&#x000b7;12), <italic>P</italic> = 0&#x000b7;028). No
significant changes were seen in the placebo arm of the study. These results suggest that
PJ consumption can alleviate key cardiovascular risk factors in overweight and obese
subjects that might be due to a reduction in both systolic and diastolic BP, possibly
through the inhibition of 11&#x003b2;-hydroxysteroid dehydrogenase type 1 enzyme activity as
evidenced by the reduction in the cortisol/cortisone ratio. The reduction in insulin
resistance might have therapeutic benefits for patients with non-insulin-dependent
diabetes, obesity and the metabolic syndrome.</p></abstract><kwd-group kwd-group-type=""><title>Key words</title><kwd>Pomegranate juice</kwd><kwd>Blood pressure</kwd><kwd>Glucocorticoids</kwd><kwd>Obesity</kwd><kwd>11&#x003b2;-Hydroxysteroid dehydrogenase</kwd><kwd>Homeostasis model assessment of insulin resistance</kwd></kwd-group><kwd-group kwd-group-type="abbreviations"><title>Abreviations</title><kwd>11&#x003b2;-HSD, 11&#x003b2;-hydroxysteroid dehydrogenase</kwd><kwd>BP, blood pressure</kwd><kwd>DBP, diastolic blood pressure</kwd><kwd>FRAP, ferric-reducing antioxidant power</kwd><kwd>HOMA-IR, homeostasis model assessment of insulin resistance</kwd><kwd>PJ, pomegranate juice</kwd><kwd>SBP, systolic blood pressure.</kwd></kwd-group><counts><page-count count="9"/></counts></article-meta></front><body><p>CVD is a major cause of mortality in Western countries, particularly in Scotland where
death rates are among the highest in the world. Dietary factors represent a key component of
the disease and specific dietary constituents are considered to be important to health.
Polyphenols are secondary metabolites widespread in the plant kingdom and form an integral
part of the human diet where it has been estimated that their total dietary intake may be as
high as 1&#x000a0;g/d<sup>(</sup><xref rid="ref1" ref-type="bibr">
<sup>1</sup>
</xref><sup>)</sup>. Polyphenols have perceived health benefits in their ability to
neutralise free radicals and reactive oxygen species, and thus cardiovascular health may be
improved, as LDL-cholesterol has a reduced capacity to be oxidised and therefore to reduce
atherogenicity and platelet aggregation<sup>(</sup><xref rid="ref2" ref-type="bibr">
<sup>2</sup>
</xref><sup>&#x02013;</sup><xref rid="ref4" ref-type="bibr">
<sup>4</sup>
</xref><sup>)</sup>. The pomegranate (<italic>Punica granatum</italic> L.) has been a
medicinal food throughout history. Pomegranate juice (PJ; also known as pomegreat pure
juice) might have potent antioxidant and anti-atherosclerotic properties attributed to its
abundance of polyphenols including ellagic acids, gallotannins and anthocyanins (cyanidin,
delphinidin and pelargonidin glycosides) and other flavonoids. The most abundant of these
polyphenols is punicalagin, an ellagitannin implicated as the bioactive constituent
responsible for &#x0003e;50&#x000a0;% of the juice's antioxidant activity<sup>(</sup><xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref><sup>,</sup><xref rid="ref6" ref-type="bibr">
<sup>6</sup>
</xref><sup>)</sup>. Numerous studies have been carried out for the identification and
quantification of phenolic compounds and their effects on antioxidant activity of PJ in
human subjects and animals<sup>(</sup><xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref><sup>&#x02013;</sup><xref rid="ref9" ref-type="bibr">
<sup>9</sup>
</xref><sup>)</sup>, and have concluded that most pomegranate flavonoids and ellagitannins
such as punicalagin and ellagic acid can be detected in the plasma and urine. However, the
levels were found to be lower than expected, which could be due to the fact that the
bioavailability process is complicated with large individual variations and requires further
investigation using a large number of volunteers. In addition, it was also discovered that
even ellagic acid metabolites such as urolithins A and B and their glucuronide and sulphate
derivatives are biologically active<sup>(</sup><xref rid="ref10" ref-type="bibr">
<sup>10</sup>
</xref><sup>&#x02013;</sup><xref rid="ref12" ref-type="bibr">
<sup>12</sup>
</xref><sup>)</sup>.</p><p>Several studies have demonstrated that consumption of PJ can exert positive effects on
cardiovascular risk, hypertension, atherosclerosis, endothelial dysfunction and
inflammation<sup>(</sup><xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref><sup>&#x02013;</sup><xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref><sup>)</sup>. Clinical studies have shown a beneficial effect on vascular health
following PJ consumption, with reduced systolic blood pressure (SBP), enhanced antioxidant
status and improved insulin resistance in type 2 diabetic and hypertensive
patients<sup>(</sup><xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref><sup>,</sup><xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref><sup>,</sup><xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref><sup>)</sup>. In addition, some researchers have shown that PJ consumption reduces
carotid intima-media thickness and blood pressure (BP)<sup>(</sup><xref rid="ref14" ref-type="bibr">
<sup>14</sup>
</xref><sup>,</sup><xref rid="ref17" ref-type="bibr">
<sup>17</sup>
</xref><sup>)</sup>. As powerful antioxidants, phenolics may protect the body from damaging
oxidation reactions<sup>(</sup><xref rid="ref18" ref-type="bibr">
<sup>18</sup>
</xref><sup>,</sup><xref rid="ref19" ref-type="bibr">
<sup>19</sup>
</xref><sup>)</sup>; however, other mechanisms may also operate which are currently under
investigation. In a limited study of hypertensive patients, consumption of PJ for 2 weeks
was shown to reduce SBP by inhibiting serum angiotensin-converting enzyme<sup>(</sup><xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref><sup>)</sup>. Obesity and diabetes are other underlying factors linked to metabolic
and cardiovascular risk<sup>(</sup><xref rid="ref14" ref-type="bibr">
<sup>14</sup>
</xref><sup>)</sup> as well as abnormal cortisol levels and metabolism<sup>(</sup><xref rid="ref20" ref-type="bibr">
<sup>20</sup>
</xref><sup>)</sup>.</p><p>The importance of cortisol in regulating BP has been highlighted in several conditions, and
chronic excessive activation of the glucocorticoid receptor is known to induce obesity,
insulin resistance, glucose intolerance and hypertension<sup>(</sup><xref rid="ref21" ref-type="bibr">
<sup>21</sup>
</xref><sup>)</sup>. Glucocorticoids exert a direct effect on the heart and blood vessels
via 11&#x003b2;-hydroxysteroid dehydrogenase type 1 enzyme (11&#x003b2;-HSD1) and 11&#x003b2;-HSD2. Increased
11&#x003b2;-HSD1 activity is implicated in the development of the metabolic syndrome and identifying
dietary constituents that influence 11&#x003b2;-HSD1 activity could lead to novel methods of
preventing CVD and associated risk factors. The association between excess cortisol and
various parameters of the metabolic syndrome, including hypertension and insulin resistance,
is now increasingly recognised<sup>(</sup><xref rid="ref22" ref-type="bibr">
<sup>22</sup>
</xref><sup>,</sup><xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref><sup>)</sup>. The aim of the present study was to examine the influence of a 4-week
consumption of PJ (Pomegreat Pure<sup>&#x000ae;</sup>) containing 1685&#x000a0;mg/l polyphenols on salivary
and urinary cortisol and cortisone levels, and their ratio as indicative of the activity of
11&#x003b2;-HSD enzymes. In addition, the assessment of cardiometabolic risk factors: BP, arterial
compliance, plasma lipid profile, glucose, insulin and insulin resistance, in a high-risk
group (age 40&#x02013;65 years) of apparently healthy male and female participants will be made.</p><sec id="sec2"><title>Experimental methods</title><sec id="sec2-1"><title>Study design</title><p>The study used a randomised, placebo-controlled, cross-over design (<xref ref-type="fig" rid="fig01">Fig. 1</xref>). Following a 1-week run-in phase, eligible subjects were
randomly assigned to receive 500&#x000a0;ml PJ containing 1685&#x000a0;mg/l polyphenols or 500&#x000a0;ml placebo
(water placed in a dark container plus the addition of equivalent carbohydrates to match
the energy content of the juice). Participants followed each intervention for 4 weeks,
after which they were crossed over to the next intervention separated by a 1-week washout
period. Participants were provided with a list of phenolic-rich foods to avoid including
green tea, red wine, dark chocolate and berries. Compliance with the dietary restrictions
was monitored with a 3-d food diary record. Compliance was also measured by assessing the
total phenolic content of 24&#x000a0;h urine samples collected at baseline, the mid-point and at
the end of the study period. All participants provided written informed consent and a
lifestyle questionnaire to determine their eligibility. The study was conducted at Queen
Margaret University and the protocol was approved by Queen Margaret University Research
Ethics Committee. This study was conducted according to the guidelines laid down in the
Declaration of Helsinki and all procedures involving human subjects were approved by the
Queen Margaret University Research Ethics Central Committee. Written informed consent was
obtained from all subjects and has been recorded and stored according to the university
guidelines. <fig id="fig01" position="float"><label>Fig. 1</label><caption><p>Flow diagram of the study design protocol.</p></caption><graphic xlink:href="S2048679012000109_fig1"/></fig></p></sec><sec id="sec2-2"><title>Inclusion and exclusion criteria</title><p>Participants were recruited by an email moderator advertisement at Queen Margaret
University, Edinburgh, UK. Volunteers were aged between 40 and 65 years with a BMI between
25 and 35&#x000a0;kg/m<sup>2</sup>. Only those sedentary or moderately active (defined as less
than two aerobic sessions per week) were included. Participants were excluded if they
presented with signs of the metabolic syndrome, i.e. fasting plasma glucose
&#x0003e;6&#x000b7;1&#x000a0;mmol/l, TAG level &#x0003e;1&#x000b7;7&#x000a0;mmol/l, low HDL-cholesterol (&#x0003c;1&#x000b7;01&#x000a0;mmol/l
for men and &#x0003c;1&#x000b7;25&#x000a0;mmol/l for women), hypertension, central obesity (waist
circumference &#x0003e;108&#x000a0;cm for men and &#x0003e;88&#x000a0;cm for women) or if they had moderate
hypercholesterolaemia. Individuals were excluded also if they reported to have CVD,
diabetes, asthma, SBP&#x000a0;&#x0003e;160&#x000a0;mmHg or diastolic blood pressure (DBP) &#x0003e;99&#x000a0;mmHg.
Individuals with thyroid gland disorders or eating disorders, as well as those taking
regular medication or nutritional supplements (such as antioxidants or fish oil) known to
affect any dependent variable measured, were also excluded.</p></sec><sec id="sec2-3"><title>Materials and chemicals</title><p>Gallic acid and Folin&#x02013;Ciocalteau's phenol regent were purchased from Sigma. Methanol
(HPLC grade) and HCl were purchased from Rathburn Chemicals. Acetone, acetic acid
(glacial) and Na<sub>2</sub>HPO<sub>4</sub> were obtained from Fisher Scientific.
Na<sub>2</sub>CO<sub>3</sub>, disodium hydrogen orthophosphate and sodium dihydrogen
orthophosphate dehydrate were purchased from BDH Chemicals Ltd. All other chemicals and
reagents were obtained from Sigma unless otherwise stated.</p></sec><sec id="sec2-4"><title>Measurements</title><p>Fasted blood was collected at baseline and at the end of the 4-week intervention period.
Plasma was obtained by centrifugation (at 1500&#x000a0;<bold><italic>g</italic></bold> for 10&#x000a0;min) within 30&#x000a0;min of blood collection and stored frozen at &#x02212;80&#x000b0;C prior to
analysis. Plasma lipids and glucose analyses were undertaken at the Clinical Biochemistry
Laboratory, Western General Hospital, Edinburgh, Scotland, UK using an automated platform
(Olympus). Fasting plasma insulin was estimated using a sensitive human Insulin ELISA kit
(GenWay), and insulin resistance (homeostasis model assessment of insulin resistance
(HOMA-IR)) was calculated by the method of Turner and co-workers<sup>(</sup><xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref><sup>)</sup> using the formula HOMA-IR&#x000a0;=&#x000a0;fasting glucose&#x000a0;&#x000d7;&#x000a0;fasting insulin/22&#x000b7;5.
Unstimulated saliva samples were collected (08.00 hours, noon and 18.00 hours) from
volunteers in sterile plastic containers at baseline and after 4 weeks of the juice or
placebo intake.</p><p>Serum NEFA were quantified using an automated enzymatic colorimetric method (Wako) at the
Rowett Institute of Nutrition and Health, Aberdeen, UK. Urinary and plasma levels of total
polyphenols<sup>(</sup><xref rid="ref25" ref-type="bibr">
<sup>25</sup>
</xref><sup>)</sup> and ferric-reducing antioxidant power (FRAP)<sup>(</sup><xref rid="ref26" ref-type="bibr">
<sup>26</sup>
</xref><sup>)</sup> were measured by established methods. Plasma levels of total phenolics
were assessed by a modification of the Folin&#x02013;Ciocalteau method as described by Serafini
<italic>et al.</italic><sup>(</sup><xref rid="ref27" ref-type="bibr">
<sup>27</sup>
</xref><sup>)</sup>. Cortisol and cortisone levels in saliva and urine samples were
estimated by using highly specific and sensitive ELISA methods published
previously<sup>(</sup><xref rid="ref28" ref-type="bibr">
<sup>28</sup>
</xref><sup>)</sup>. The ratio of cortisol to cortisone was calculated to give an
indication of the activity of 11&#x003b2;-HSD1. All samples from the same subject were tested on
the same day to prevent any inter-day variation. A validated automated A&#x00026;D Medical
UA-767 BP monitor (A&#x00026;D Medical) was used to measure BP according to Grassi
<italic>et al.</italic><sup>(</sup><xref rid="ref29" ref-type="bibr">
<sup>29</sup>
</xref><sup>)</sup>. Three readings of BP were usually taken at each visit and the average
was calculated. Arterial compliance was assessed by pulse wave velocity using a Vicorder&#x02122;,
(Skidmore Medical), and again three measurements were taken at each visit.</p></sec><sec id="sec2-5"><title>Statistical analysis</title><p>All statistical analyses were performed using SPSS for Windows, version 16.10 (SPSS
Inc.). <italic>P</italic>&#x000a0;&#x02264;&#x000a0;0&#x000b7;05 was considered significant. Continuous normally
distributed data are expressed as mean values and standard deviations unless otherwise
stated. Differences in baseline characteristics were examined using an independent-samples
paired Student's <italic>t</italic> test with BMI, age, waist circumference, fasting
insulin, glucose, lipid profile, BP, urinary and plasma total polyphenols and FRAP as the
dependent variables. ANOVA were conducted using the general linear model procedure to
assess the differences in the effect of PJ and placebo on outcome measures. The models
included the main effects of treatment, time and treatment&#x02013;time interaction. Bonferroni
adjustment was used to account for multiple testing.</p><p>To examine whether the effect of PJ on BP, insulin and HOMA-IR was dependent on BMI, we
also ran a series of linear regression models. Changes in BP, insulin and HOMA-IR were
modelled as dependent variables. BMI, treatment and BMI&#x02013;treatment interaction were fitted
as predictors, as shown in the following equation:<disp-formula id="eqnU1"><graphic xlink:href="S2048679012000109_eqnU1.jpg" mimetype="image" position="float"><alt-text>y=\left({a_{\rm 1} x_{\rm 1} } \right)+\left({a_{\rm 2} x_{\rm 2} }
\right)+\left({a_{\rm 3} x_{\rm 3} } \right)+a_{\rm 4}\comma \;</alt-text></graphic></disp-formula>where <italic>y</italic> is the change in outcome from the baseline per
person per treatment group; <italic>x</italic><sub>1</sub> is the dummy variable, 0 for
placebo and 1 for PJ; <italic>x</italic><sub>2</sub> is the BMI expressed as a continuous
variable; <italic>x</italic><sub>3</sub> is the product term for dummy variable and BMI;
and <italic>a</italic><sub>1&#x02013;4</sub> is the &#x003b2; coefficients.</p></sec></sec><sec sec-type="results" id="sec3"><title>Results</title><sec id="sec3-1"><title>Subjects</title><p>Eligible participants were aged between 40 and 65 years with a BMI between 25 and
35&#x000a0;kg/m<sup>2</sup> (<xref ref-type="table" rid="tab01">Table 1</xref>). In this
randomised, placebo-controlled, cross-over study, twenty-eight volunteers (twelve males
and sixteen females) completed the study and each consumed 500&#x000a0;ml/d of PJ for a period of
4 weeks. Of the total number recruited, eight were excluded for one of the reasons
mentioned in <xref ref-type="fig" rid="fig01">Fig. 1</xref> and two subjects dropped out
of the study due to the inconvenience of travelling to the university campus following
baseline assessment. <table-wrap id="tab01" position="float"><label>Table 1</label><caption><p>Anthropometric, pulse wave velocity (PWV), ferric-reducing antioxidant power
(FRAP), total phenolics (TP), plasma cholesterol and lipid profile measurements at
baseline and following 2 and 4 weeks of pomegranate juice consumption (Mean values
and standard deviations)</p></caption><graphic xlink:href="S2048679012000109_tab1"/><table-wrap-foot><fn id="tab-fn01"><p>HOMA-IR, homeostasis model assessment of insulin resistance.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec3-2"><title>Anthropometric and metabolic results</title><p>The 4-week intervention did not significantly change plasma levels of lipids (total
cholesterol, TAG, LDL-cholesterol or HDL-cholesterol) or glucose concentrations, which
were all within the anticipated physiological range (<xref ref-type="table" rid="tab01">Table 1</xref>). There was a significant reduction in pulse wave velocity after 2 weeks
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;035) and 4 weeks of PJ consumption. There was also a significant
reduction in both SBP and DBP in the treatment group compared with the control group
(<xref ref-type="table" rid="tab01">Table 1</xref>), SBP from 136&#x000b7;2&#x000a0;(<sc>sd</sc>&#x000a0;6&#x000b7;3) to
131&#x000b7;1&#x000a0;(<sc>sd</sc>&#x000a0;7&#x000b7;6) (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;033) to 128&#x000b7;9&#x000a0;(<sc>sd</sc>&#x000a0;5&#x000b7;1)&#x000a0;mmHg
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;034) after 2 and 4 weeks, respectively. DBP decreased from
80&#x000b7;27&#x000a0;(<sc>sd</sc>&#x000a0;4&#x000b7;29) to 75&#x000b7;5&#x000a0;(<sc>sd</sc>&#x000a0;5&#x000b7;17)&#x000a0;mmHg (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;031)
after 2 weeks of fruit juice consumption.</p><p>No significant changes in body weight or BMI were observed; however, eleven of the
twenty-one participants showed a decrease in plasma NEFA levels following fruit juice
consumption for 4 weeks (from 0&#x000b7;483&#x000a0;(<sc>sd</sc>&#x000a0;0&#x000b7;16) to 0&#x000b7;396&#x000a0;(<sc>sd</sc>&#x000a0;0&#x000b7;14)&#x000a0;mmol/l,
<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;017), and this was not observed in the placebo group. Plasma
antioxidant capacity was significantly increased following 4 weeks of PJ intake; FRAP
increased from 1098&#x000a0;(<sc>sd</sc>&#x000a0;170&#x000b7;5) to 1241&#x000a0;(<sc>sd</sc>&#x000a0;173&#x000b7;7)&#x000a0;&#x003bc;mol Fe(II)/l
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;001) following fruit juice consumption. Plasma total phenols
were also significantly increased from 3&#x000b7;23&#x000a0;(<sc>sd</sc>&#x000a0;0&#x000b7;41) to
3&#x000b7;48&#x000a0;(<sc>sd</sc>&#x000a0;0&#x000b7;46)&#x000a0;mmol gallic acid equivalents/l (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;015).
Urinary antioxidant capacity was significantly increased following 2 and 4 weeks of PJ
intake. After 2 weeks, the FRAP level went up from 3&#x000b7;46&#x000a0;(<sc>sd</sc>&#x000a0;0&#x000b7;92) to
4&#x000b7;58&#x000a0;(<sc>sd</sc>&#x000a0;1&#x000b7;11)&#x000a0;mmol Fe(II)/d (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;012). The urinary total
phenolics level was also significantly increased from 2&#x000b7;59&#x000a0;(<sc>sd</sc>&#x000a0;0&#x000b7;71) to
3&#x000b7;33&#x000a0;(<sc>sd</sc>&#x000a0;0&#x000b7;81)&#x000a0;mmol gallic acid equivalents/d (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;001).
There was no significant change in the plasma lipid profile, BP, fasting glucose and
insulin, plasma and urinary FRAP and total phenolics following the placebo arm of the
study (<xref ref-type="table" rid="tab02">Table 2</xref>). <table-wrap id="tab02" position="float"><label>Table 2</label><caption><p>Blood pressure (BP), pulse wave velocity (PWV), plasma cholesterol and lipid
profile measurements at baseline and following 4 weeks of placebo drink consumption
(Mean values and standard deviations)</p></caption><graphic xlink:href="S2048679012000109_tab2"/><table-wrap-foot><fn id="tab-fn02"><p>TC, total cholesterol; HDL-C, HDL-cholesterol; LDL-C, LDL-cholesterol; HOMA-IR,
homeostasis model assessment of insulin resistance.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec3-3"><title>Hormonal results</title><p>The results of cortisol and cortisone levels are shown in <xref ref-type="fig" rid="fig02">Fig. 2</xref>. Urinary free cortisol levels were reduced following PJ
consumption compared to basal values, but not significantly. No significant difference was
obtained in urinary free cortisone output. When the free cortisol/cortisone ratio was
calculated, there was a significant reduction in urinary (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;009) and
salivary ratios (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;024), indicating a possible effect on 11&#x003b2;-HSD1
activity. Placebo data showed no significant difference (the urinary basal ratio was
1&#x000b7;029&#x000a0;(<sc>sd</sc>&#x000a0;0&#x000b7;28) and post-placebo 1&#x000b7;042&#x000a0;(<sc>sd</sc>&#x000a0;0&#x000b7;34)). There was a
significant reduction of fasting plasma insulin levels from 9&#x000b7;364&#x000a0;(<sc>sd</sc>&#x000a0;5&#x000b7;81) to
7&#x000b7;53&#x000a0;(<sc>sd</sc>&#x000a0;4&#x000b7;12)&#x000a0;mIU/l (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;025) and of insulin resistance
(HOMA-IR) from 2&#x000b7;216&#x000a0;(<sc>sd</sc>&#x000a0;1&#x000b7;43) to 1&#x000b7;825&#x000a0;(<sc>sd</sc>&#x000a0;1&#x000b7;12)
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;028) (<xref ref-type="table" rid="tab01">Table 1</xref>). There
was no significant change in all the parameters tested following the placebo arm of the
study (<xref ref-type="table" rid="tab02">Table 2</xref>). <fig id="fig02" position="float"><label>Fig. 2</label><caption><p>Glucocorticoid results. (a) Urinary free cortisol and cortisone outputs at baseline
(&#x025a0;) and post-pomegranate juice (PJ; &#x02592;) and (b) urinary (&#x02593;) and salivary (///) free
cortisol/cortisone ratios. Values are means, with standard errors represented by
vertical bars. Mean value was significantly reduced following pomegranate juice
intake compared with baseline: * <italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;024, **
<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;009.</p></caption><graphic xlink:href="S2048679012000109_fig2"/></fig></p></sec><sec id="sec3-4"><title>Blood pressure, insulin and homeostasis model of insulin resistance results</title><p>The effect on SBP, DBP, insulin and HOMA-IR was also studied using ANOVA. Here the
changes in response between the basal and the intervention (pomegranate or placebo) were
calculated, and the results are shown in <xref ref-type="fig" rid="fig03">Figs. 3</xref>
and <xref ref-type="fig" rid="fig04">4</xref>. For BP scores, the data were analysed using
the differences between the basal values and those following PJ or placebo intake. The
effects of PJ intake compared with the placebo were significant for all the variables when
both males and females were pooled (<xref ref-type="fig" rid="fig03">Fig. 3</xref>).
Separately, the effects in males were not always significant, but in females, the
differences were. For the effect on plasma insulin and HOMA-IR (<xref ref-type="fig" rid="fig04">Fig. 4</xref>), the percentage differences from basal values were analysed
(e.g. 100&#x000a0;&#x000d7;&#x000a0;basal insulin/insulin PJ and 100&#x000a0;&#x000d7;&#x000a0;basal insulin/insulin placebo). Again, the
results indicate that a significance effect was more apparent when all the data were
pooled together. <fig id="fig03" position="float"><label>Fig. 3</label><caption><p>Effect of pomegranate juice consumption on blood pressure (BP) reduction. There
were significant reductions in systolic BP (a) and diastolic BP (b) differences from
basal values when both male and female data were pooled. Separate effects in males
were not always significant, but those in females were. Values are means, with
standard errors represented by vertical bars. * <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05, **
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;01.</p></caption><graphic xlink:href="S2048679012000109_fig3"/></fig>
<fig id="fig04" position="float"><label>Fig. 4</label><caption><p>Effect of pomegranate juice consumption on insulin (a) and homeostasis model
assessment of insulin-resistance (HOMA-IR) (b) calculated as percentage difference
from basal values. Values are means, with standard errors represented by vertical
bars. There were significant reductions in percentage fasting plasma insulin
differences in females and pooled data but not in males. However, there were
significant reductions in percentage of HOMA-IR differences for males, females and
pooled data. * <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05, **
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;01, *** <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;001.</p></caption><graphic xlink:href="S2048679012000109_fig4"/></fig></p><p>For the results of linear regression models investigating whether the effects of PJ on
BP, insulin and HOMA-IR were dependent on BMI, we also ran a series of regression analyses
between the changes in BP, insulin and HOMA-IR and BMI. The association between BMI and
changes in SBP or DBP following intake of PJ or placebo (<xref ref-type="fig" rid="fig05">Fig. 5</xref>) showed a significant interaction between BMI and treatment for SBP
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;013) and DBP (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;022). On the other hand,
the association between BMI and changes in insulin and HOMA-IR following the intake of PJ
or placebo (<xref ref-type="fig" rid="fig06">Fig. 6</xref>) showed that there was no
significant interaction between BMI and treatment for insulin (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;469)
or HOMA-IR (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;431). <fig id="fig05" position="float"><label>Fig. 5</label><caption><p>Association between BMI and changes in systolic blood pressure (SBP) (a) or
diastolic blood pressure (DBP) (b) following intake of pomegranate juice (&#x02666;) or
placebo (<inline-graphic xlink:href="S2048679012000109_inline1.jpg" mimetype="image"/>). The graph
shows trend lines for pomegranate juice (. . . .) and placebo (- - -). There was a
significant interaction between BMI and treatment for SBP
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;013) and DBP (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;022).</p></caption><graphic xlink:href="S2048679012000109_fig5"/></fig>
<fig id="fig06" position="float"><label>Fig. 6</label><caption><p>Association between BMI and changes in insulin (a) and homeostasis model assessment
of insulin resistance (HOMA-IR) (b) following intake of pomegranate juice (&#x02666;) or
placebo (<inline-graphic xlink:href="S2048679012000109_inline1.jpg" mimetype="image"/>). The graph
shows trend lines for pomegranate juice (. . . .) and placebo (- - -). There was no
significant interaction between BMI and treatment for insulin
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;469) or HOMA-IR (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;431).</p></caption><graphic xlink:href="S2048679012000109_fig6"/></fig></p></sec></sec><sec sec-type="discussion" id="sec4"><title>Discussion</title><p>The present study was conducted to investigate the cardio-metabolic effects of PJ
consumption over a 4-week period in apparently healthy male and female participants at high
CVD risk. Previous clinical studies have shown beneficial effects on cardiovascular risk:
reduced SBP, improved insulin resistance in non-insulin-dependent diabetes mellitus and
hypertensive patients following the consumption of PJ<sup>(</sup><xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref><sup>,</sup><xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref><sup>,</sup><xref rid="ref30" ref-type="bibr">
<sup>30</sup>
</xref><sup>,</sup><xref rid="ref31" ref-type="bibr">
<sup>31</sup>
</xref><sup>)</sup>. Similarly, we also observed a significant reduction in SBP and DBP
following 2 and 4 weeks of PJ consumption. The drop in SBP was from 0&#x000b7;5 to 22&#x000a0;mmHg and the
drop in DBP was from 0 to 12&#x000a0;mmHg. Those with higher baseline BP had the most marked drop in
their BP following PJ consumption (e.g. for subject 16, BP decreased from 160/91 to 141/74
compared with subject 1 from 135/64 to 130/61). One of the main objectives of this study was
to investigate whether the drop in BP might be caused by inactivation of 11&#x003b2;-HSD1, which
converts cortisone to the active steroid, cortisol. The circulating level of cortisol is an
important factor in BP regulation and can also exert negative effects on the cardiovascular
system at an autocrine level. There are two isozymes of 11&#x003b2;-HSD that catalyse the
interconversion of active cortisol and inactive cortisone. 11&#x003b2;-HSD1 is mostly abundant in
liver and adipose human tissue. It functions mainly as an oxoreductase converting cortisone
to cortisol. We have shown that PJ intake has the potential for inhibiting 11&#x003b2;-HSD1 activity
as is evident from the reduction in the cortisol/cortisone ratio in both urine and saliva.
The role of this enzyme in hypertension has been reported previously, for example, in the
syndrome of apparent mineralocorticoid excess<sup>(</sup><xref rid="ref32" ref-type="bibr">
<sup>32</sup>
</xref><sup>)</sup>. A combination of assaying urinary free cortisone and free cortisol is a
powerful method of assessing 11&#x003b2;-HSD1 activity that proved to be very advantageous in this
regard<sup>(</sup><xref rid="ref33" ref-type="bibr">
<sup>33</sup>
</xref><sup>)</sup><italic>.</italic> However, we could not directly assess the enzyme
activity in this study (by PCR expression for example) due to protocol limitations. In
addition, it has been postulated that selective inhibitors of 11&#x003b2;-HSD1 may lower blood
glucose and HOMA-IR in type 2 diabetic animal models<sup>(</sup><xref rid="ref34" ref-type="bibr">
<sup>34</sup>
</xref><sup>)</sup>. Cortisol is known to be essential for the long-term maintenance of
blood glucose and could also unfavourably influence BP and lipid profile as it can induce
oxidative stress that has been linked to hyperinsulinaemia and insulin
resistance<sup>(</sup><xref rid="ref22" ref-type="bibr">
<sup>22</sup>
</xref><sup>,</sup><xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref><sup>)</sup>. This might explain our findings that PJ consumption has improved
insulin resistance in our cohort. In this study, there was a reduction in free cortisol
levels but it was not significant. Further investigation to establish whether
tissue-specific alteration in 11&#x003b2;-HSD1 occurs following PJ consumption, in particular the
effects on liver and adipose tissues, would be warranted. It is widely accepted that obesity
is an inflammatory condition that may play an important role in
hypertension<sup>(</sup><xref rid="ref35" ref-type="bibr">
<sup>35</sup>
</xref><sup>,</sup><xref rid="ref36" ref-type="bibr">
<sup>36</sup>
</xref><sup>)</sup>. Linear regression analysis of our results has shown that there was a
significant interaction between BMI and the reduction in SBP and DBP following PJ intake.
The drop in BP might also be partly explained by the inhibition of angiotensin-converting
enzyme activity following PJ intake as reported by Aviram &#x00026;
Dornfield<sup>(</sup><xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref><sup>)</sup>, a reduction in carotid intima-media thickness<sup>(</sup><xref rid="ref14" ref-type="bibr">
<sup>14</sup>
</xref><sup>,</sup><xref rid="ref17" ref-type="bibr">
<sup>17</sup>
</xref><sup>)</sup>, an improvement of arterial elasticity (as we have observed in this
study) or a combination of all these factors.</p><p>We did not find any significant changes in plasma total cholesterol, HDL, LDL or TAG
following PJ intake, which was similar to the placebo results. This could be due to the
small number of participants and their age group or the short washout period (1 week) that
perhaps was not enough for levels to go to baseline. We accept that this can be regarded as
one limitation of this study. However, studies conducted in both human subjects and animals
have shown conflicting results. While some studies demonstrated a reduction in TAG and total
cholesterol levels following PJ consumption (3&#x02013;10&#x000a0;%), other studies have found no effects on
circulating lipids<sup>(</sup><xref rid="ref37" ref-type="bibr">
<sup>37</sup>
</xref><sup>)</sup>. However, several studies have consistently found a reduction in
oxidised LDL levels and plaque formation associated with atherosclerosis following PJ
consumption<sup>(</sup><xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref><sup>,</sup><xref rid="ref38" ref-type="bibr">
<sup>38</sup>
</xref><sup>,</sup><xref rid="ref39" ref-type="bibr">
<sup>39</sup>
</xref><sup>)</sup>.</p><p>As powerful antioxidants polyphenols present in fruits may help protect the body from
damaging oxidation reactions; however, the mechanism by which antioxidants exert their
effects is not fully understood. Certainly, antioxidants play a key role in the scavenging
of free radicals generated through oxidative metabolism and may offer protection to
bio-molecules (DNA, lipids and proteins) against damage. However, there is increasing
evidence that individual phenolics or certain classes of phenolics may exert additional
beneficial effects independent of their antioxidant properties. Among these are the
deceleration of prostate cancer<sup>(</sup><xref rid="ref40" ref-type="bibr">
<sup>40</sup>
</xref><sup>)</sup>, anticancer effect in human breast cancer<sup>(</sup><xref rid="ref41" ref-type="bibr">
<sup>41</sup>
</xref><sup>)</sup>, enhancement of NO biological actions<sup>(</sup><xref rid="ref42" ref-type="bibr">
<sup>42</sup>
</xref><sup>)</sup> and Alzheimer's disease prevention<sup>(</sup><xref rid="ref43" ref-type="bibr">
<sup>43</sup>
</xref><sup>)</sup>. In addition, phenolic extracts from plants were suggested to cause
insulin-like effects in glucose utilisation, and effectively inhibit intestinal
&#x003b1;-glucosidase activity. The inhibitory effectiveness of the extracts were thought to be
related to their anthocyanin content, in particular diacylated anthocyanins from these
sources that were most effective<sup>(</sup><xref rid="ref44" ref-type="bibr">
<sup>44</sup>
</xref><sup>)</sup>. Moreover, certain phenolics also inhibit &#x003b1;-amylase activity, which
could prove synergistic to their potential therapeutic effect on post-meal blood glucose
levels. Tannins and ellagic acid in particular are potent inhibitors of &#x003b1;-amylase activity.
Tannic acid and tannin-rich non-alcoholic components of red wine have been shown to reduce
serum glucose levels following a starch-rich meal in patients with non-insulin-dependent
diabetes mellitus<sup>(</sup><xref rid="ref45" ref-type="bibr">
<sup>45</sup>
</xref><sup>)</sup>. A recent review of the role of antioxidants in abnormal glucose
metabolism<sup>(</sup><xref rid="ref46" ref-type="bibr">
<sup>46</sup>
</xref><sup>)</sup> has concluded that experimental data are in favour of a beneficial role,
but clinical data in human subjects remain controversial.</p><p>The question of bioavailability of pomegranate polyphenols remains controversial. Some
authors have concluded that phenolic compounds such as those present in pomegranate are
poorly absorbed and do not markedly contribute to antioxidant activity<sup>(</sup><xref rid="ref47" ref-type="bibr">
<sup>47</sup>
</xref><sup>,</sup><xref rid="ref48" ref-type="bibr">
<sup>48</sup>
</xref><sup>)</sup>. However, an overwhelming number of studies have shown demonstrable
health benefits following the consumption of PJ or extract mainly due to the
biotransformation of pomegranate polyphenols<sup>(</sup><xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref><sup>&#x02013;</sup><xref rid="ref8" ref-type="bibr">
<sup>8</sup>
</xref><sup>,</sup><xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref><sup>,</sup><xref rid="ref37" ref-type="bibr">
<sup>37</sup>
</xref><sup>&#x02013;</sup><xref rid="ref39" ref-type="bibr">
<sup>39</sup>
</xref><sup>,</sup><xref rid="ref41" ref-type="bibr">
<sup>41</sup>
</xref><sup>&#x02013;</sup><xref rid="ref44" ref-type="bibr">
<sup>44</sup>
</xref><sup>)</sup>. There is also now good evidence that even ellagitannin metabolites such
as urolithins A, B and C and their glucuronides and sulphates are biologically
active<sup>(</sup><xref rid="ref10" ref-type="bibr">
<sup>10</sup>
</xref><sup>&#x02013;</sup><xref rid="ref12" ref-type="bibr">
<sup>12</sup>
</xref><sup>)</sup>. In the present study, we observed significant reductions in both
insulin and insulin resistance (HOMA-IR) following PJ consumption. Diabetic patients may be
more prone to oxidative stress because as hyperglycaemia facilitates the production of free
radicals<sup>(</sup><xref rid="ref49" ref-type="bibr">
<sup>49</sup>
</xref><sup>)</sup>, dietary antioxidants may be important therapeutically in the control of
non-insulin-dependent diabetes mellitus. There have been reports that naturally occurring
polyphenols can inhibit pancreatic lipase and thereby influence fat digestion and affect
energy intake. A recent study investigated the effects of different berry phenolic extracts
on their ability to inhibit pancreatic lipase <italic>in vitro</italic><sup>(</sup><xref rid="ref50" ref-type="bibr">
<sup>50</sup>
</xref><sup>)</sup>. The most effective were from the <italic>Rubus</italic> family (i.e.
raspberry, cloudberry and bramble) and strawberry. There is also a suggestion that
ellagitannins present in berries and pomegranate could be important for lipase inhibition.
Commercial PJ is known to contain significant levels of both ellagitannins and anthocyanins
which may influence fat digestion and excretion. Although we did not investigate the
influence of PJ on pancreatic lipase activity <italic>in vitro,</italic> future studies will
focus on this important aspect. In the present study, we did not find a significant
reduction in overall body weight; however, we did observe a trend towards a reduction in
waist circumference and plasma NEFA in some of our subjects. The role of NEFA in human
obesity appears to be important, and experimental evidence links the NEFA-induced presser
response to sympathetic activation<sup>(</sup><xref rid="ref51" ref-type="bibr">
<sup>51</sup>
</xref><sup>)</sup>. Abdominal obesity is linked to increased NEFA levels, which are
associated with an increase in BP and seem to be resistant to suppression by
insulin<sup>(</sup><xref rid="ref52" ref-type="bibr">
<sup>52</sup>
</xref><sup>&#x02013;</sup><xref rid="ref54" ref-type="bibr">
<sup>54</sup>
</xref><sup>)</sup>.</p></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>This study was partly funded by RJA Foods, UK. We would like to thank RJA Foods, UK for
supplying the PJ and all the volunteers who took part in this study. The authors are
indebted to Dr Baukje de Soos, The Rowett Institute of Nutrition and Health, Aberdeen
University for facilitating the NEFA analysis.</p><p>The authors declare no conflicts of interest. E. A. S. A. D. and C. T. were responsible for
designing, and conducting the research and statistical analysis and preparing the
manuscript. C. T. provided essential reagents and assisted with the antioxidant analysis. N.
F. S. performed the plasma and urinary FRAP and total polyphenols assays. S. A. M. was
responsible for statistical analyses. I. D. was responsible for resource allocation.</p></ack><ref-list><title>References</title><ref id="ref1"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Manach</surname><given-names>C</given-names></name>
<name><surname>Scalbert</surname><given-names>A</given-names></name>
<name><surname>Morand</surname><given-names>C</given-names></name>
<etal/>
(
<year>2004</year>
<article-title>Polyphenols: food sources and bioavailability</article-title>
<source><italic>Am J Clin Nutr</italic></source>
<volume>79</volume>
<fpage>727</fpage>
<lpage>747</lpage>
<pub-id pub-id-type="pmid">15113710</pub-id></mixed-citation></ref><ref id="ref2"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Sumner</surname><given-names>MD</given-names></name>
<name><surname>Elliott-Eller</surname><given-names>M</given-names></name>
<name><surname>Weidner</surname><given-names>G</given-names></name>
<etal/>
(
<year>2005</year>
<article-title>Effects of pomegranate juice consumption on myocardial perfusion in
patients with coronary heart disease</article-title>
<source><italic>Am J Cardiol</italic></source>
<volume>96</volume>
<fpage>810</fpage>
<lpage>814</lpage>
<pub-id pub-id-type="pmid">16169367</pub-id></mixed-citation></ref><ref id="ref3"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Aviram</surname><given-names>M</given-names></name>
<name><surname>Dornfeld</surname><given-names>L</given-names></name>
<name><surname>Rosenblat</surname><given-names>M</given-names></name>
<etal/>
(
<year>2000</year>
<article-title>Pomegranate juice consumption reduces oxidative stress, atherogenic
modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic
apolipoprotein E-deficient mice</article-title>
<source><italic>Am J Clin Nutr</italic></source>
<volume>71</volume>
<fpage>1062</fpage>
<lpage>1076</lpage>
<pub-id pub-id-type="pmid">10799367</pub-id></mixed-citation></ref><ref id="ref4"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Seeram</surname><given-names>NP</given-names></name>
<name><surname>Adams</surname><given-names>LS</given-names></name>
<name><surname>Henning</surname><given-names>SM</given-names></name>
<etal/>
(
<year>2005</year>
<article-title><italic>In vitro</italic> antiproliferative, apoptotic and antioxidant
activities of punicalagin, ellagic acid and a total pomegranate tannin extract are
enhanced in combination with other polyphenols as found in pomegranate juice</article-title>
<source><italic>J Nutr Biochem</italic></source>
<volume>16</volume>
<fpage>360</fpage>
<lpage>367</lpage>
<pub-id pub-id-type="pmid">15936648</pub-id></mixed-citation></ref><ref id="ref5"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Longtin</surname><given-names>R</given-names></name>
(
<year>2003</year>
<article-title>The pomegranate: nature's power fruit</article-title>
<source><italic>J Natl Cancer Inst</italic></source>
<volume>95</volume>
<fpage>346</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="pmid">12618495</pub-id></mixed-citation></ref><ref id="ref6"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Gil</surname><given-names>MI</given-names></name>
<name><surname>Tomas-Barberan</surname><given-names>FA</given-names></name>
<name><surname>Hess-Pierce</surname><given-names>B</given-names></name>
<etal/>
(
<year>2000</year>
<article-title>Antioxidant activity of pomegranate juice and relationship with phenolic
composition and processing</article-title>
<source><italic>J Agric Food Chem</italic></source>
<volume>48</volume>
<fpage>4581</fpage>
<lpage>4589</lpage>
<pub-id pub-id-type="pmid">11052704</pub-id></mixed-citation></ref><ref id="ref7"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Seeram</surname><given-names>NP</given-names></name>
<name><surname>Henning</surname><given-names>SM</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<etal/>
(
<year>2006</year>
<article-title>Pomegranate juice ellagitannin metabolites are present in human plasma and
some persist in urine for up to 48 hours</article-title>
<source><italic>J Nutr</italic></source>
<volume>136</volume>
<fpage>2481</fpage>
<lpage>2485</lpage>
<pub-id pub-id-type="pmid">16988113</pub-id></mixed-citation></ref><ref id="ref8"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Mertens-Talcott</surname><given-names>SU</given-names></name>
<name><surname>Jilma-Stohlawetz</surname><given-names>P</given-names></name>
<name><surname>Rios</surname><given-names>J</given-names></name>
<etal/>
(
<year>2006</year>
<article-title>Absorption, metabolism, and antioxidant effects of pomegranate
(<italic>Punica granatum</italic> L.) polyphenols after ingestion of a standardized
extract in healthy human volunteers</article-title>
<source><italic>J Agric Food Chem</italic></source>
<volume>54</volume>
<fpage>8956</fpage>
<lpage>8961</lpage>
<pub-id pub-id-type="pmid">17090147</pub-id></mixed-citation></ref><ref id="ref9"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Mousavinejad</surname><given-names>G</given-names></name>
<name><surname>Emam-Djomeh</surname><given-names>Z</given-names></name>
<name><surname>Rezaei</surname><given-names>K</given-names></name>
<etal/>
(
<year>2009</year>
<article-title>Identification and quantification of phenolic compounds and their effects
on antioxidant activity in pomegranate juices of eight Iranian cultivars</article-title>
<source><italic>Food Chem</italic></source>
<volume>115</volume>
<fpage>1274</fpage>
<lpage>1278</lpage>
</mixed-citation></ref><ref id="ref10"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Bialonska</surname><given-names>D</given-names></name>
<name><surname>Kasimsetty</surname><given-names>SG</given-names></name>
<name><surname>Khan</surname><given-names>SI</given-names></name>
<etal/>
(
<year>2009</year>
<article-title>Urolithins, intestinal microbial metabolites of pomegranate ellagitannins,
exhibit potent antioxidant activity in a cell-based assay</article-title>
<source><italic>J Agric Food Chem</italic></source>
<volume>57</volume>
<fpage>10181</fpage>
<lpage>10186</lpage>
<pub-id pub-id-type="pmid">19824638</pub-id></mixed-citation></ref><ref id="ref11"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Gonz&#x000e1;lez-Barrio</surname><given-names>R</given-names></name>
<name><surname>Truchado</surname><given-names>P</given-names></name>
<name><surname>Ito</surname><given-names>H</given-names></name>
<etal/>
(
<year>2011</year>
<article-title>UV and MS identification of urolithins and nasutins, the bioavailable
metabolites of ellagitannins and ellagic acid in different mammals</article-title>
<source><italic>J Agric Food Chem</italic></source>
<volume>59</volume>
<fpage>1152</fpage>
<lpage>1162</lpage>
<pub-id pub-id-type="pmid">21265540</pub-id></mixed-citation></ref><ref id="ref12"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Cerda</surname><given-names>B</given-names></name>
<name><surname>Periago</surname><given-names>P</given-names></name>
<name><surname>Espin</surname><given-names>JC</given-names></name>
<etal/>
(
<year>2005</year>
<article-title>Identification of urolithin A as a metabolite produced by human colon
microflora from ellagic acid and related compounds</article-title>
<source><italic>J Agric Food Chem</italic></source>
<volume>53</volume>
<fpage>5571</fpage>
<lpage>5576</lpage>
<pub-id pub-id-type="pmid">15998116</pub-id></mixed-citation></ref><ref id="ref13"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Basu</surname><given-names>A</given-names></name>
&#x00026;
<name><surname>Penugonda</surname><given-names>K</given-names></name>
(
<year>2009</year>
<article-title>Pomegranate juice: a heart healthy juice</article-title>
<source><italic>Nutr Rev</italic></source>
<volume>67</volume>
<fpage>49</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="pmid">19146506</pub-id></mixed-citation></ref><ref id="ref14"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Avriam</surname><given-names>M</given-names></name>
<name><surname>Rosenblat</surname><given-names>M</given-names></name>
<name><surname>Gaitini</surname><given-names>D</given-names></name>
<etal/>
(
<year>2003</year>
<article-title>PJ consumption for 3 years by patients with carotid artery stenosis reduces
common carotid intima-media thickness, blood pressure and LDL oxidation</article-title>
<source><italic>Clin Nutr</italic></source>
<volume>23</volume>
<fpage>423</fpage>
<lpage>433</lpage>
</mixed-citation></ref><ref id="ref15"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Avriam</surname><given-names>M</given-names></name>
&#x00026;
<name><surname>Dornfield</surname><given-names>L</given-names></name>
(
<year>2001</year>
<article-title>Pomegranate juice consumption inhibits serum angiotensin converting enzyme
activity and reduces systolic blood pressure</article-title>
<source><italic>Atherosclerosis</italic></source>
<volume>158</volume>
<fpage>195</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="pmid">11500191</pub-id></mixed-citation></ref><ref id="ref16"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Stowe</surname><given-names>CB</given-names></name>
(
<year>2010</year>
<article-title>The effects of pomegranate juice consumption on blood pressure and
cardiovascular health</article-title>
<source><italic>Complement Ther Clin Pract</italic></source>
<volume>17</volume>
<fpage>113</fpage>
<lpage>115</lpage>
<pub-id pub-id-type="pmid">21457902</pub-id></mixed-citation></ref><ref id="ref17"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Davidson</surname><given-names>MH</given-names></name>
<name><surname>Maki</surname><given-names>KC</given-names></name>
<name><surname>Dicklin</surname><given-names>MR</given-names></name>
<etal/>
(
<year>2009</year>
<article-title>Effect of consumption of pomegranate juice on carotid intima-media
thickness in men and women at moderate risk for coronary heart disease</article-title>
<source><italic>Am J Cardiol</italic></source>
<volume>104</volume>
<fpage>936</fpage>
<lpage>942</lpage>
<pub-id pub-id-type="pmid">19766760</pub-id></mixed-citation></ref><ref id="ref18"><label>18</label><mixed-citation publication-type="book">
<name><surname>Crozier</surname><given-names>A</given-names></name>
<name><surname>Yokota</surname><given-names>T</given-names></name>
<name><surname>Jaganath</surname><given-names>IB</given-names></name>
<etal/>
(
<year>2006</year>
<article-title>Secondary metabolites in fruits, vegetables, beverages and other plant
based dietary components</article-title>
. In
<source><italic>Plant Secondary Metabolites: Occurrence, Structure and Role in the Human
Diet</italic></source>
, pp.
<fpage>208</fpage>
<lpage>302</lpage>
[
<name><surname>Crozier</surname><given-names>A</given-names></name>
<name><surname>Clifford</surname><given-names>MN</given-names></name>
and
<name><surname>Ashihara</surname><given-names>H</given-names></name>
, editors].
<publisher-loc>Oxford, UK</publisher-loc>
<publisher-name>Blackwell</publisher-name>
</mixed-citation></ref><ref id="ref19"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Seeram</surname><given-names>NP</given-names></name>
<name><surname>Aviram</surname><given-names>M</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<etal/>
(
<year>2008</year>
<article-title>Comparison of antioxidant potency of commonly consumed polyphenol-rich
beverages in the United States</article-title>
<source><italic>J Agric Food Chem</italic></source>
<volume>56</volume>
<fpage>1415</fpage>
<lpage>1422</lpage>
<pub-id pub-id-type="pmid">18220345</pub-id></mixed-citation></ref><ref id="ref20"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Vicennati</surname><given-names>V</given-names></name>
&#x00026;
<name><surname>Pasquali</surname><given-names>R</given-names></name>
(
<year>2000</year>
<article-title>Abnormalities of the hypothalamic&#x02013;pituitary&#x02013;adrenal axis in nondepressed
women with abdominal obesity and relations with insulin resistance: evidence for a
central and a peripheral alteration</article-title>
<source><italic>J Clin Endocrinol Metab</italic></source>
<volume>85</volume>
<fpage>4093</fpage>
<lpage>4098</lpage>
<pub-id pub-id-type="pmid">11095438</pub-id></mixed-citation></ref><ref id="ref21"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Walker</surname><given-names>BR</given-names></name>
<name><surname>Connacher</surname><given-names>AA</given-names></name>
<name><surname>Webb</surname><given-names>DJ</given-names></name>
<etal/>
(
<year>1992</year>
<article-title>Glucocorticoids and blood pressure: a role for the cortisol/cortisone
shuttle in the control of vascular tone in man</article-title>
<source><italic>Clin Sci</italic></source>
<volume>83</volume>
<fpage>171</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="pmid">1327632</pub-id></mixed-citation></ref><ref id="ref22"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Duclos</surname><given-names>M</given-names></name>
<name><surname>Pereira</surname><given-names>PM</given-names></name>
<name><surname>Barat</surname><given-names>P</given-names></name>
<etal/>
(
<year>2005</year>
<article-title>Increased cortisol bioavailability, abdominal obesity and the metabolic
syndrome in obese women</article-title>
<source><italic>Obes Res</italic></source>
<volume>13</volume>
<fpage>1157</fpage>
<lpage>1166</lpage>
<pub-id pub-id-type="pmid">16076984</pub-id></mixed-citation></ref><ref id="ref23"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Kidambi</surname><given-names>S</given-names></name>
<name><surname>Kitchen</surname><given-names>JM</given-names></name>
<name><surname>Grim</surname><given-names>CE</given-names></name>
<etal/>
(
<year>2007</year>
<article-title>Association of adrenal steroids with hypertension and the metabolic
syndrome in blacks</article-title>
<source><italic>Hypertension</italic></source>
<volume>49</volume>
<fpage>704</fpage>
<lpage>711</lpage>
<pub-id pub-id-type="pmid">17159085</pub-id></mixed-citation></ref><ref id="ref24"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Matthews</surname><given-names>DR</given-names></name>
<name><surname>Hosker</surname><given-names>JP</given-names></name>
<name><surname>Rudenski</surname><given-names>AS</given-names></name>
<etal/>
(
<year>1985</year>
<article-title>Homeostasis model assessment: insulin resistance and beta-cell function
from fasting plasma glucose and insulin concentrations in man</article-title>
<source><italic>Diabetologia</italic></source>
<volume>28</volume>
<fpage>412</fpage>
<lpage>419</lpage>
<pub-id pub-id-type="pmid">3899825</pub-id></mixed-citation></ref><ref id="ref25"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Singleton</surname><given-names>VL</given-names></name>
&#x00026;
<name><surname>Rossi</surname><given-names>JA</given-names></name>
(
<year>1965</year>
<article-title>Colorimetry of total phenolics with phosphomolybdic&#x02013;phosphotungstic
reagents</article-title>
<source><italic>Am J Enol Vitol</italic></source>
<volume>16</volume>
<fpage>144</fpage>
<lpage>158</lpage>
</mixed-citation></ref><ref id="ref26"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Benzie</surname><given-names>IFF</given-names></name>
&#x00026;
<name><surname>Strain</surname><given-names>JJ</given-names></name>
(
<year>1996</year>
<article-title>The ferric reducing ability of plasma (FRAP) as a measure of &#x02018;antioxidant
power&#x02019;. The FRAP assay</article-title>
<source><italic>Anal Biochem</italic></source>
<volume>239</volume>
<fpage>70</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="pmid">8660627</pub-id></mixed-citation></ref><ref id="ref27"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Serafini</surname><given-names>M</given-names></name>
<name><surname>Maiani</surname><given-names>G</given-names></name>
&#x00026;
<name><surname>Ferro-Luzzi</surname><given-names>A</given-names></name>
(
<year>1998</year>
<article-title>Alcohol-free red wine enhances plasma antioxidant capacity in humans</article-title>
<source><italic>J Nutr</italic></source>
<volume>128</volume>
<fpage>1003</fpage>
<lpage>1007</lpage>
<pub-id pub-id-type="pmid">9614160</pub-id></mixed-citation></ref><ref id="ref28"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Al-Dujaili</surname><given-names>EAS</given-names></name>
<name><surname>Kenyon</surname><given-names>CJ</given-names></name>
<name><surname>Nicol</surname><given-names>MR</given-names></name>
<etal/>
(
<year>2011</year>
<article-title>Liquorice and glycyrrhetinic acid increase DHEA and deoxycorticosterone
levels <italic>in vivo</italic> and <italic>in vitro</italic> by inhibiting adrenal
SULT2A1 activity</article-title>
<source><italic>Mol Cell Endocrinol</italic></source>
<volume>336</volume>
<fpage>102</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="pmid">21184804</pub-id></mixed-citation></ref><ref id="ref29"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Grassi</surname><given-names>D</given-names></name>
<name><surname>Lippi</surname><given-names>C</given-names></name>
<name><surname>Necozione</surname><given-names>S</given-names></name>
<etal/>
(
<year>2005</year>
<article-title>Short-term administration of dark chocolate is followed by a significant
increase in insulin sensitivity and a decrease in blood pressure in healthy persons</article-title>
<source><italic>Am J Clin Nutr</italic></source>
<volume>81</volume>
<fpage>611</fpage>
<lpage>614</lpage>
<pub-id pub-id-type="pmid">15755830</pub-id></mixed-citation></ref><ref id="ref30"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Chong</surname><given-names>MFF</given-names></name>
<name><surname>Macdonald</surname><given-names>R</given-names></name>
&#x00026;
<name><surname>Lovegrove</surname><given-names>JA</given-names></name>
(
<year>2010</year>
<article-title>Fruit polyphenols and CVD risk: a review of human intervention studies</article-title>
<source><italic>Br J Nutr</italic></source>
<volume>104</volume>
<fpage>S28</fpage>
<lpage>S39</lpage>
<pub-id pub-id-type="pmid">20955648</pub-id></mixed-citation></ref><ref id="ref31"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Rosenblatt</surname><given-names>M</given-names></name>
<name><surname>Hayek</surname><given-names>T</given-names></name>
&#x00026;
<name><surname>Aviram</surname><given-names>M</given-names></name>
(
<year>2006</year>
<article-title>Anti-oxidative effects of pomegranate juice consumption by diabetic
patients on serum and on macrophages</article-title>
<source><italic>Atherosclerosis</italic></source>
<volume>187</volume>
<fpage>363</fpage>
<lpage>371</lpage>
<pub-id pub-id-type="pmid">16226266</pub-id></mixed-citation></ref><ref id="ref32"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Edwards</surname><given-names>CR</given-names></name>
<name><surname>Stewart</surname><given-names>PM</given-names></name>
<name><surname>Burt</surname><given-names>D</given-names></name>
<etal/>
(
<year>1988</year>
<article-title>Localisation of 11beta-hydroxysteroid dehydrogenase tissue specific
protector of the mineralocorticoid receptor</article-title>
<source><italic>Lancet</italic></source>
<volume>ii</volume>
<fpage>986</fpage>
<lpage>989</lpage>
<pub-id pub-id-type="pmid">2902493</pub-id></mixed-citation></ref><ref id="ref33"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Palermo</surname><given-names>M</given-names></name>
<name><surname>Shackleton</surname><given-names>CH</given-names></name>
<name><surname>Mantero</surname><given-names>F</given-names></name>
<etal/>
(
<year>1996</year>
<article-title>Urinary free cortisone and the assessment of 11&#x003b2;-hydroxysteroid
dehydrogenase activity in man</article-title>
<source><italic>Clin Endocrinol <italic>(</italic>Oxf<italic>)</italic></italic></source>
<volume>45</volume>
<fpage>605</fpage>
<lpage>611</lpage>
<pub-id pub-id-type="pmid">8977758</pub-id></mixed-citation></ref><ref id="ref34"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Tomlinson</surname><given-names>JW</given-names></name>
<name><surname>Finney</surname><given-names>J</given-names></name>
<name><surname>Gay</surname><given-names>C</given-names></name>
<etal/>
(
<year>2008</year>
<article-title>Impaired glucose tolerance and insulin resistance are associated with
increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated
hepatic 5alpha-reductase activity</article-title>
<source><italic>Diabetes</italic></source>
<volume>57</volume>
<fpage>2652</fpage>
<lpage>2660</lpage>
<pub-id pub-id-type="pmid">18633104</pub-id></mixed-citation></ref><ref id="ref35"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Rahmouni</surname><given-names>K</given-names></name>
<name><surname>Correia</surname><given-names>MLG</given-names></name>
<name><surname>Haynes</surname><given-names>WG</given-names></name>
<etal/>
(
<year>2005</year>
<article-title>Obesity-associated hypertension, new insights into mechanisms</article-title>
<source><italic>Hypertension</italic></source>
<volume>45</volume>
<fpage>9</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="pmid">15583075</pub-id></mixed-citation></ref><ref id="ref36"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Chen</surname><given-names>T</given-names></name>
<name><surname>Li</surname><given-names>W</given-names></name>
<name><surname>Wang</surname><given-names>Y</given-names></name>
<etal/>
(
<year>2012</year>
<article-title>Body mass index and hypertension among Chinese governmental and
institutional employees in Beijing</article-title>
<source><italic>Angiology</italic></source>
<volume>63</volume>
<fpage>337</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="pmid">21873347</pub-id></mixed-citation></ref><ref id="ref37"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Esmaillzadeh</surname><given-names>A</given-names></name>
<name><surname>Tahbaz</surname><given-names>F</given-names></name>
<name><surname>Gaieni</surname><given-names>I</given-names></name>
<etal/>
(
<year>2004</year>
<article-title>Concentrated pomegranate juice improves lipid profiles in diabetic patients
with hyperlipidemia</article-title>
<source><italic>J Med Food</italic></source>
<volume>7</volume>
<fpage>305</fpage>
<lpage>308</lpage>
<pub-id pub-id-type="pmid">15383223</pub-id></mixed-citation></ref><ref id="ref38"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Kaplan</surname><given-names>M</given-names></name>
<name><surname>Hayek</surname><given-names>T</given-names></name>
<name><surname>Raz</surname><given-names>A</given-names></name>
<etal/>
(
<year>2001</year>
<article-title>Pomegranate juice supplementation to atherosclerotic mice reduces
macrophage lipid peroxidation, cellular cholesterol accumulation and development of
atherosclerosis</article-title>
<source><italic>J Nutr</italic></source>
<volume>131</volume>
<fpage>2082</fpage>
<lpage>2089</lpage>
<pub-id pub-id-type="pmid">11481398</pub-id></mixed-citation></ref><ref id="ref39"><label>39</label><mixed-citation publication-type="journal">
<name><surname>de Nigris</surname><given-names>F</given-names></name>
<name><surname>Williams-Ignarro</surname><given-names>S</given-names></name>
<name><surname>Botti</surname><given-names>C</given-names></name>
<etal/>
(
<year>2006</year>
<article-title>Pomegranate juice reduces oxidized low-density lipoprotein down regulation
of endothelial nitric oxide synthase in human coronary endothelial cells</article-title>
<source><italic>Nitric Oxide</italic></source>
<volume>15</volume>
<fpage>259</fpage>
<lpage>263</lpage>
<pub-id pub-id-type="pmid">16413211</pub-id></mixed-citation></ref><ref id="ref40"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Malik</surname><given-names>A</given-names></name>
<name><surname>Afaq</surname><given-names>F</given-names></name>
<name><surname>Sarfaraz</surname><given-names>S</given-names></name>
<etal/>
(
<year>2005</year>
<article-title>Pomegranate fruit juice for chemoprevention and chemotherapy of prostate
cancer</article-title>
<source><italic>Proc Natl Acad Sci USA</italic></source>
<volume>102</volume>
<fpage>14813</fpage>
<lpage>14818</lpage>
<pub-id pub-id-type="pmid">16192356</pub-id></mixed-citation></ref><ref id="ref41"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Kim</surname><given-names>ND</given-names></name>
<name><surname>Mehta</surname><given-names>R</given-names></name>
<name><surname>Yu</surname><given-names>W</given-names></name>
<etal/>
(
<year>2002</year>
<article-title>Chemopreventive and adjuvant therapeutic potential of pomegranate
(<italic>Punica granatum</italic>) for human breast cancer</article-title>
<source><italic>Breast Cancer Res Treat</italic></source>
<volume>71</volume>
<fpage>203</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="pmid">12002340</pub-id></mixed-citation></ref><ref id="ref42"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Ignarro</surname><given-names>LJ</given-names></name>
<name><surname>Byrns</surname><given-names>RE</given-names></name>
<name><surname>Sumi</surname><given-names>D</given-names></name>
<etal/>
(
<year>2006</year>
<article-title>Pomegranate juice protects nitric oxide against oxidative destruction and
enhances the biological actions of nitric oxide</article-title>
<source><italic>Nitric Oxide</italic></source>
<volume>15</volume>
<fpage>93</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="pmid">16626982</pub-id></mixed-citation></ref><ref id="ref43"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Hartman</surname><given-names>RE</given-names></name>
<name><surname>Shah</surname><given-names>A</given-names></name>
<name><surname>Fagan</surname><given-names>AM</given-names></name>
<etal/>
(
<year>2006</year>
<article-title>Pomegranate juice decreases amyloid load and improves behaviour in a mouse
model of Alzheimer's disease</article-title>
<source><italic>Neurobiol Dis</italic></source>
<volume>24</volume>
<fpage>506</fpage>
<lpage>515</lpage>
<pub-id pub-id-type="pmid">17010630</pub-id></mixed-citation></ref><ref id="ref44"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Matsui</surname><given-names>T</given-names></name>
<name><surname>Ueda</surname><given-names>A</given-names></name>
<name><surname>Oki</surname><given-names>T</given-names></name>
<etal/>
(
<year>2001</year>
<article-title>&#x003b1;-Glucosidase inhibitory action of natural acylated anthocyanins</article-title>
<source><italic>J Agric Food Chem</italic></source>
<volume>49</volume>
<fpage>1952</fpage>
<lpage>1956</lpage>
<pub-id pub-id-type="pmid">11308352</pub-id></mixed-citation></ref><ref id="ref45"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Gin</surname><given-names>H</given-names></name>
<name><surname>Rigalleau</surname><given-names>V</given-names></name>
<name><surname>Caubet</surname><given-names>O</given-names></name>
<etal/>
(
<year>1999</year>
<article-title>Effects of red wine, tannic acid or ethanol on glucose tolerance in
non-insulin dependent diabetic patients and on starch digestibility <italic>in
vitro</italic></article-title>
<source><italic>Metabolism</italic></source>
<volume>48</volume>
<fpage>1179</fpage>
<lpage>1183</lpage>
<pub-id pub-id-type="pmid">10484061</pub-id></mixed-citation></ref><ref id="ref46"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Avignon</surname><given-names>A</given-names></name>
<name><surname>Hokayem</surname><given-names>M</given-names></name>
<name><surname>Bisbal</surname><given-names>C</given-names></name>
<etal/>
(
<year>2012</year>
<article-title>Dietary antioxidants: do they have a role in the ongoing fight against
abnormal glucose metabolism?</article-title>
<source><italic>Nutrition</italic></source>
<volume>28</volume>
<fpage>715</fpage>
<lpage>721</lpage>
<pub-id pub-id-type="pmid">22571840</pub-id></mixed-citation></ref><ref id="ref47"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Cerd&#x000e1;</surname><given-names>B</given-names></name>
<name><surname>Esp&#x000ed;n</surname><given-names>JC</given-names></name>
<name><surname>Parra</surname><given-names>S</given-names></name>
<etal/>
(
<year>2004</year>
<article-title>The potent <italic>in vitro</italic> antioxidant ellagitannins from
pomegranate juice are metabolised into bioavailable but poor antioxidant
hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans</article-title>
<source><italic>Eur J Nutr</italic></source>
<volume>43</volume>
<fpage>205</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="pmid">15309440</pub-id></mixed-citation></ref><ref id="ref48"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Larrosa</surname><given-names>M</given-names></name>
<name><surname>Garc&#x000ed;a-Conesa</surname><given-names>MT</given-names></name>
<name><surname>Esp&#x000ed;n</surname><given-names>JC</given-names></name>
<etal/>
(
<year>2010</year>
<article-title>Ellagitannins, ellagic acid and vascular health</article-title>
<source><italic>Mol Aspects Med</italic></source>
<volume>31</volume>
<fpage>513</fpage>
<lpage>539</lpage>
<pub-id pub-id-type="pmid">20837052</pub-id></mixed-citation></ref><ref id="ref49"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Martin-Gallan</surname><given-names>P</given-names></name>
<name><surname>Carrascossa</surname><given-names>A</given-names></name>
<name><surname>Gussinye</surname><given-names>M</given-names></name>
<etal/>
(
<year>2003</year>
<article-title>Biomarkers of diabetes-associated oxidative stress and antioxidant status
in young diabetic patients with or without subclinical complications</article-title>
<source><italic>Free Radical Biol Med</italic></source>
<volume>34</volume>
<fpage>1563</fpage>
<lpage>1574</lpage>
<pub-id pub-id-type="pmid">12788476</pub-id></mixed-citation></ref><ref id="ref50"><label>50</label><mixed-citation publication-type="journal">
<name><surname>McDougall</surname><given-names>GJ</given-names></name>
<name><surname>Kulkarni</surname><given-names>NN</given-names></name>
&#x00026;
<name><surname>Stewart</surname><given-names>D</given-names></name>
(
<year>2009</year>
<article-title>Berry polyphenols inhibit pancreatic lipase activity <italic>in
vitro</italic></article-title>
<source><italic>Food Chem</italic></source>
<volume>115</volume>
<fpage>193</fpage>
<lpage>199</lpage>
</mixed-citation></ref><ref id="ref51"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Florian</surname><given-names>JP</given-names></name>
&#x00026;
<name><surname>Pawelczyk</surname><given-names>JA</given-names></name>
(
<year>2010</year>
<article-title>Non-esterified fatty acids increase arterial pressure via central
sympathetic activation in humans</article-title>
<source><italic>Clin Sci</italic></source>
<volume>118</volume>
<fpage>61</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="pmid">19426144</pub-id></mixed-citation></ref><ref id="ref52"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Schlaich</surname><given-names>M</given-names></name>
(
<year>2010</year>
<article-title>Central sympathetic outflow to skeletal muscle: the major link between
non-esterified fatty acids and elevated blood pressure</article-title>
<source><italic>Clin Sci</italic></source>
<volume>118</volume>
<fpage>43</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="pmid">19594440</pub-id></mixed-citation></ref><ref id="ref53"><label>53</label><mixed-citation publication-type="journal">
<name><surname>Fagot-Campagna</surname><given-names>A</given-names></name>
<name><surname>Balkau</surname><given-names>B</given-names></name>
<name><surname>Simon</surname><given-names>D</given-names></name>
<etal/>
(
<year>1998</year>
<article-title>High free fatty acid concentration: an independent risk factor for
hypertension in the Paris Prospective Study</article-title>
<source><italic>Int J Epidemiol</italic></source>
<volume>27</volume>
<fpage>808</fpage>
<lpage>813</lpage>
<pub-id pub-id-type="pmid">9839737</pub-id></mixed-citation></ref><ref id="ref54"><label>54</label><mixed-citation publication-type="journal">
<name><surname>Ferrannini</surname><given-names>E</given-names></name>
<name><surname>Balkau</surname><given-names>B</given-names></name>
<name><surname>Coppack</surname><given-names>SW</given-names></name>
<etal/>
(
<year>2007</year>
<article-title>Insulin resistance, insulin response, and obesity as indicators of
metabolic risk</article-title>
<source><italic>J Clin Endocrinol Metab</italic></source>
<volume>92</volume>
<fpage>2885</fpage>
<lpage>2892</lpage>
<pub-id pub-id-type="pmid">17504904</pub-id></mixed-citation></ref></ref-list></back></article>